13605-65-7Relevant articles and documents
Synthesis, spectral characterization, and X-ray crystal structure of Pd(II) complexes containing the orthometallated C,C-chelating ligand C 6H 4-PPh 2C(H)C(O)CH 2Cl
Karami, Kazem,Amouzad, Sara,Hosseini-Kharat, Mahboubeh,Rizzoli, Corrado
, p. 1774 - 1783 (2013)
The ylide-phosphonium salt [PPh3CH2C(O)CH 2Cl]+Cl- (1) reacted with Pd(OAc)2 to give the chloro-bridged dinuclear complex [Pd{C(H)PPh3C(O)CH 2Cl}(μ-Cl)(OAc)]2/su
Structure - neuromuscular blocking activity relationships of ketophosphonium salts
Houssin,Henichart,Foulon,Baert
, p. 888 - 891 (1980)
-
FLUORESCENT SYSTEMS FOR BIOLOGICAL IMAGING AND USES THEREOF
-
Page/Page column 26; 28; 51, (2021/02/12)
The invention relates to compounds of formula I, in which Y, Ar1, Ar2, X, R1 and R2 are defined herein, and to their use in a variety of biological imaging techniques and therapeutic methods. In aspects, the invention relates to conjugates comprising the compounds of formula I and their associated uses and therapeutic uses.
AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
-
Paragraph 0557; 0558; 0559, (2015/07/22)
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.